Mark A. Varney - Concepedia

Author

Mark A. Varney

Also Known As

M A Varney, M Varney, M. A. Varney, M. VARNEY, M. Varney, M.A Varney, M.A. Varney, MA Varney, Mark A Varney, Mark A. Varney

Publications

5.7K

Citations

H-Index

Concepts

All Affiliations

Neurolixis (United States)Merck & Co., Inc., Rahway, NJ, USA (United States)General Atomics (United States)Sunovion (United States)Cortex Pharmaceuticals (United States)

About

Mark A. Varney is an author at Neurolixis (United States) specializing in medicine, neuropharmacology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	39	3.6K
2	Social Sciences	13	15	1.7K
3	Natural Sciences	5	5	142
4	Health Sciences	2	2	83
5	Allergy	1	1	33

Mark A. Varney

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist F. Gasparini, Kurt Lingenhöhl, Natacha Stoehr, Neuropharmacology BiochemistryFunctional SelectivityMedicineMechanism Of ActionReceptor (Biochemistry)	1999	720
Effects of ketamine and n-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268 Daniel S. Lorrain, Christopher Baccei, Linda J. Bristow, Neuroscience PsychiatryNeurophysiologyNeurotransmitterRat Prefrontal CortexPsychopharmacology	2003	429
3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]- pyridine: A Potent and Highly Selective Metabotropic Glutamate Subtype 5 Receptor Antagonist with Anxiolytic Activity Nicholas D. P. Cosford, Lida Tehrani, Jeffrey Roppe, Journal of Medicinal Chemistry Receptor AntagonistPsychopharmacologyPharmacotherapyCompound 9Off-target Activity	2002	400
Differential distribution of voltage‐gated calcium channel alpha‐2 delta (α<sub>2</sub>δ) subunit mRNA‐containing cells in the rat central nervous system and the dorsal root ganglia Rebecca L. Cole, Sandra Lechner, Mark E. Williams, The Journal of Comparative Neurology Synaptic TransmissionNeurotransmitterNeurotransmissionPeripheral NervesCellular Neurobiology	2005	223
SIB-1757 and SIB-1893: Selective, Noncompetitive Antagonists of Metabotropic Glutamate Receptor Type 5 Mark A. Varney, Nicholas D. P. Cosford, Christine Jachec, Journal of Pharmacology and Experimental Therapeutics	1999	189
(R, S)-4-Phosphonophenylglycine, a Potent and Selective Group III Metabotropic Glutamate Receptor Agonist, Is Anticonvulsive and Neuroprotective In Vivo F. Gasparini, Valeria Bruno, Giuseppe Battaglia, Journal of Pharmacology and Experimental Therapeutics	1999	174
Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function Katherine Walker, M. Bowes, Moh Panesar, Neuropharmacology Pain MedicineMedicineNeuropathic PainMolecular PainNeuropharmacology	2001	165
Pharmacological Characterization and Identification of Amino Acids Involved in the Positive Modulation of Metabotropic Glutamate Receptor Subtype 2 Hervé Schaffhauser, Blake A. Rowe, Sylvia Morales, Molecular Pharmacology	2003	158
The Behavioral Profile of the Potent and Selective mGlu5 Receptor Antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in Rodent Models of Anxiety Chris S Busse, Jesse Brodkin, David Tattersall, Neuropsychopharmacology PsychiatryBehavioral NeuroscienceMedicineBehavioural PharmacologyRodent Models	2004	157
Oxytocin-stimulated phosphoinositide hydrolysis in human myometrial cells: involvement of pertussis toxin-sensitive and -insensitive G-proteins S Phaneuf, G. Nicholas Europe‐Finner, Mark A. Varney, Journal of Endocrinology	1993	150

Page 1